Jane Devane
Profile
Ms. Jane Devane is a Director-Clinical Operations at Athenex, Inc.
Ms. Devane was previously employed as a Principal by Merck & Co., Inc. and a Principal by Schering-Plough Corp.
She received her undergraduate degree from Fairleigh Dickinson University.
Former positions of Jane Devane
Companies | Position | End |
---|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
MERCK & CO., INC. | Corporate Officer/Principal | - |
ATHENEXPAR | Chief Tech/Sci/R&D Officer | - |
Training of Jane Devane
Fairleigh Dickinson University | Undergraduate Degree |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Private companies | 2 |
---|---|
Athenex, Inc.
Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Stock Market
- Insiders
- Jane Devane